LAPROSTAMOL 50/5 latanoprost 50 microgram/mL and timolol 5 mg/mL (as maleate) eye drops solution bottle

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

latanoprost, Quantity: 0.05 mg/mL; timolol maleate, Quantity: 6.83 mg/mL (Equivalent: timolol, Qty 5 mg/mL)

Commercializzato da:

Arrotex Pharmaceuticals Pty Ltd

INN (Nome Internazionale):

Latanoprost,Timolol maleate

Forma farmaceutica:

Eye Drops, solution

Composizione:

Excipient Ingredients: sodium hydroxide; dibasic sodium phosphate dodecahydrate; purified water; benzalkonium chloride; hydrochloric acid; monobasic sodium phosphate dihydrate; sodium chloride

Via di somministrazione:

Ophthalmic

Confezione:

3 x 2.5 mL, 1 x 2.5 mL

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. Latanoprost/timolol (50 microgram/mL/5 mg/mL) eye drops should not be used to initiate therapy.

Dettagli prodotto:

Visual Identification: Clear, colourless liquid.; Container Type: Bottle; Container Material: LDPE; Container Life Time: 21 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2017-03-20